SCHEMBL7618366

SCHEMBL7618366

O=c1[nH]c2nc([N+](=O)[O-])[nH]c2c(=O)n1CC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.44
ADORA2A P29274 2/20 0.42
ADORA1 P30542 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
MTOR P42345 11/20 0.41
PIK3CA P42336 3/20 0.39
GSK3A P49840 2/20 0.39
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7620841 0.99 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3MTOR
SCHEMBL7624371 0.96 ADORA2B (0.43) ADORA2BADORA2AADORA1ADORA3MTOR
SCHEMBL7616703 0.94 ADORA2B (0.47) ADORA2BADORA2AADORA1ADORA3
SCHEMBL7617653 0.81 ADORA2B (0.50) ADORA2BADORA2AADORA1ADORA3MTOR
SCHEMBL7269993 0.80 PDE4A (0.57) ADORA2BADORA2AADORA1ADORA3
SCHEMBL7618352 0.80 ADORA2A (0.46) ADORA2BADORA2AADORA1MTORPIK3CA
SCHEMBL7269747 0.79 PDE4A (0.59) ADORA2BADORA2AADORA1ADORA3
SCHEMBL7620828 0.79 ADORA1 (0.45) ADORA2BADORA2AADORA1MTORPIK3CA
SCHEMBL7623857 0.78 ADORA2B (0.52) ADORA2BADORA3MTOR
SCHEMBL7624361 0.76 ADORA1 (0.43) ADORA2BADORA2AADORA1MTORPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030666-A4 NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY SMITHKLINE BEECHAM (US) 2002-10-16 EP disclosed
EP-1030666-A1 NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY Smithkline Beecham (US) 2000-08-30 EP disclosed
WO-1999020280-A1 NOVEL USE OF COMPOUNDS FOR ANTI-PRURITIC ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 1999-04-29 WO disclosed